MANGALAM DRUGS AND ORGANICS
|
The Current P/B Ratio of MANGALAM DRUGS AND ORGANICS is 1.26.
Share Price | ₹113.7 | Dec 26,2024 |
Market Cap | ₹179.6 Cr | |
Book Value | ₹142.3 Cr | Mar2024 - Standalone Results |
Price/Book | 1.26x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of MANGALAM DRUGS AND ORGANICS
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹179.6 Cr] as on Dec 26,2024
(/) Book Value [ ₹142.3 Cr] based on Mar2024 - Standalone Results
(=) P/B Ratio [ 1.26x ]
Thus, for MANGALAM DRUGS AND ORGANICS , the investors are currently willing to pay '1.26 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of MANGALAM DRUGS AND ORGANICS !
The chart below summarizes the trend in P/B Ratio of MANGALAM DRUGS AND ORGANICS over the last five years.
Historical PB (Price/Book ) ratio chart of MANGALAM DRUGS AND ORGANICS
PB Ratio Performance Analysis for MANGALAM DRUGS AND ORGANICS
- MANGALAM DRUGS AND ORGANICS 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.96x.
- MANGALAM DRUGS AND ORGANICS 's operated at median p/b ratio of 1.03x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MANGALAM DRUGS AND ORGANICS 's p/b ratio peaked in Mar2021 at 1.2x.
- MANGALAM DRUGS AND ORGANICS 's p/b ratio hit its five-year low in Mar2020 of 0.46x.
How does MANGALAM DRUGS AND ORGANICS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
MANGALAM DRUGS AND ORGANICS | 142.35 | 1.26 | 179.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.94 | 441,838.0 |
CIPLA LTD | 26,619.90 | 4.52 | 120,270.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 4.02 | 113,077.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.87 | 96,553.2 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.50 | 156,107.0 |
MANKIND PHARMA LTD | 9,339.84 | 12.87 | 120,212.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 16.87 | 115,643.0 |
LUPIN LTD | 14,175.80 | 7.02 | 99,532.1 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.44 | 72,945.8 |
ABBOTT INDIA LTD | 3,658.73 | 16.63 | 60,844.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs MANGALAM DRUGS AND ORGANICS 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 1.26x |
Max industry PB | 16.87x |
Median industry PB | 6.94x |
Average industry PB | 8.09x |
You may also like the below Video Courses